Table 2. Phenotype of purified tumor... | American Society of Hematology

Table 2.

Phenotype of purified tumor cells after a 6-day culture

AntigenPatients:	IL-3					GM-CSF
AntigenPatients:	CAT	CAD	GEN	GUE	LAI	CAT	CAD	GEN
CD4	10	91	95	81	73	91	42	86
Monocyte
CD13	80	11	15	9	37	72	30	25
CD14	2	1	1	0	4	1	3	2
CD33	61	1	30	19	8	74	20	44
CD64	3	1	2	4	nd	1	5	4
Natural killer cells
CD56	72	6	11	28	77	77	35	21
Dendritic cells
CD1a	74	8	94	22	11	57	42	88
CD1c	82	16	72	29	5	94	69	93
CD11c	65	47	91	50	55	65	nd	66
CD83	3	30	65	30	nd	nd	31	35
Antigen-presenting cells
CD40	53	88	98	96	81	nd	68	94
CD80	12	82	72	84	56	33	33	68
CD86	47	87	81	77	59	76	49	77

AntigenPatients:	IL-3					GM-CSF
AntigenPatients:	CAT	CAD	GEN	GUE	LAI	CAT	CAD	GEN
CD4	10	91	95	81	73	91	42	86
Monocyte
CD13	80	11	15	9	37	72	30	25
CD14	2	1	1	0	4	1	3	2
CD33	61	1	30	19	8	74	20	44
CD64	3	1	2	4	nd	1	5	4
Natural killer cells
CD56	72	6	11	28	77	77	35	21
Dendritic cells
CD1a	74	8	94	22	11	57	42	88
CD1c	82	16	72	29	5	94	69	93
CD11c	65	47	91	50	55	65	nd	66
CD83	3	30	65	30	nd	nd	31	35
Antigen-presenting cells
CD40	53	88	98	96	81	nd	68	94
CD80	12	82	72	84	56	33	33	68
CD86	47	87	81	77	59	76	49	77

Percentages of positive cells were determined by 2- or 3-color flow cytometry after 6-day culture with IL-3 (10 ng/mL) or GM-CSF (500 U/mL).

nd indicates not done.